RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00046370.xml
PDF herunterladen
CC BY 4.0 · Glob Med Genet 2022; 09(02): 082-089
DOI: 10.1055/s-0042-1743259
DOI: 10.1055/s-0042-1743259
Review Article
Psoriasis: An Immunogenetic Perspective
Abstract
Psoriasis is an erythematous-squamous dermatosis with a polygenic inheritance history. Both environmental and genetic factors play a role in the etiology of the disease. Over the past two decades, numerous linkage analyzes and genome-wide association studies have been conducted to investigate the role of genetic variation in disease pathogenesis and progression. To date, >70 psoriasis susceptibility loci have been identified, including HLA-Cw6, IL12B, IL23R, and LCE3B/3C. Some genetic markers are used in clinical diagnosis, prognosis, treatment, and personalized new drug development that can further explain the pathogenesis of psoriasis. This review summarizes the immunological mechanisms involved in the etiopathogenesis of psoriasis and recent advances in susceptibility genes and highlights new potential targets for therapeutic intervention.
Authors' Contributions
A.K. did the conceptualization. M.K. made a figure. Manuscript preparation, writing, and editing were done by A.K. and M.K.
Publikationsverlauf
Eingereicht: 29. November 2021
Angenommen: 29. Dezember 2021
Artikel online veröffentlicht:
25. Februar 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Gisondi P, Bellinato F, Girolomoni G, Albanesi C. Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities. Front Pharmacol 2020; 11: 117
- 2 Liu T, Li S, Ying S. et al. The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front Immunol 2020; 11: 594735
- 3 Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590
- 4 Xu X, Zhang HY. The immunogenetics of psoriasis and implications for drug repositioning. Int J Mol Sci 2017; 18 (12) E2650
- 5 Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 2015; 64: 66-73
- 6 Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, Adamski Z. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity 2016; 49 (07) 435-450
- 7 Membrive Jiménez C, Pérez Ramírez C, Sánchez Martín A. et al. Influence of genetic polymorphisms on response to biologics in moderate-to-severe psoriasis. J Pers Med 2021; 11 (04) 293
- 8 Caputo V, Strafella C, Termine A. et al. Overview of the molecular determinants contributing to the expression of psoriasis and psoriatic arthritis phenotypes. J Cell Mol Med 2020; 24 (23) 13554-13563
- 9 Gourraud PA, Khankhanian P, Cereb N. et al. HLA diversity in the 1000 Genomes dataset. PLoS One 2014; 9 (07) e97282
- 10 Helms C, Saccone NL, Cao L. et al. Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum Genet 2005; 118 (3-4): 466-476
- 11 Mabuchi T, Ota T, Manabe Y. et al. HLA-C*12:02 is a susceptibility factor in late-onset type of psoriasis in Japanese. J Dermatol 2014; 41 (08) 697-704
- 12 Jadon D, Tillett W, Wallis D. et al. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology (Oxford) 2013; 52 (02) 261-266
- 13 Strange A, Capon F, Spencer CC. et al; Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42 (11) 985-990
- 14 Wu X, Zhao Z. Associations between ERAP1 gene polymorphisms and psoriasis susceptibility: a meta-analysis of case-control studies. BioMed Res Int 2021; 2021: 5515868
- 15 Zavattaro E, Ramezani M, Sadeghi M. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphisms and psoriasis susceptibility: a systematic review and meta-analysis. Gene 2020; 736: 144416
- 16 Zhang XJ, Huang W, Yang S. et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009; 41 (02) 205-210
- 17 Bowes J, Flynn E, Ho P. et al. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann Rheum Dis 2010; 69 (12) 2199-2203
- 18 Docampo E, Rabionet R, Riveira-Muñoz E. et al. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. Arthritis Rheum 2010; 62 (05) 1246-1251
- 19 Chiraz BS, Myriam A, Ines Z. et al. Deletion of late cornified envelope genes, LCE3C_LCE3B-del, is not associated with psoriatic arthritis in Tunisian patients. Mol Biol Rep 2014; 41 (06) 4141-4146
- 20 Docampo E, Giardina E, Riveira-Muñoz E. et al. Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis. Arthritis Rheum 2011; 63 (07) 1860-1865
- 21 Zheng HF, Zuo XB, Lu WS. et al. Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population. J Dermatol Sci 2011; 61 (02) 124-128
- 22 Li M, Wu Y, Chen G. et al. Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population. J Invest Dermatol 2011; 131 (08) 1639-1643
- 23 Ameen M, Allen MH, Fisher SA. et al. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations. Clin Exp Dermatol 2005; 30 (04) 414-418
- 24 Wu Y, Wang B, Liu JL, Gao XH, Chen HD, Li YH. Association of -619C/T polymorphism in CDSN gene and psoriasis risk: a meta-analysis. Genet Mol Res 2011; 10 (04) 3632-3640
- 25 Wiśniewski A, Matusiak Ł, Szczerkowska-Dobosz A, Nowak I, Kuśnierczyk P. HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis. Mol Genet Genomics 2018; 293 (04) 957-966
- 26 Madonna S, Scarponi C, Sestito R, Pallotta S, Cavani A, Albanesi C. The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes. J Immunol 2010; 185 (04) 2467-2481
- 27 Ray-Jones H, Duffus K, McGovern A. et al. Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31. BMC Biol 2020; 18 (01) 47
- 28 Hollox EJ, Huffmeier U, Zeeuwen PL. et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40 (01) 23-25
- 29 Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004; 111 (03) 273-281
- 30 Labarthe MP, Bosco D, Saurat JH, Meda P, Salomon D. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol 1998; 111 (01) 72-76
- 31 Sun LD, Cheng H, Wang ZX. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 2010; 42 (11) 1005-1009
- 32 Stylianaki EA, Karpouzis A, Tripsianis G, Veletza S. Assessment of gap junction protein beta-2 rs3751385 gene polymorphism in psoriasis vulgaris. J Clin Med Res 2019; 11 (09) 642-650
- 33 Moorchung N, Vasudevan B, Chatterjee M, Mani NS, Grewal RS. Interleukin-1 gene polymorphisms and their relation with NFκB expression and histopathological features in psoriasis. Indian J Dermatol 2015; 60 (05) 432-438
- 34 Tarlow JK, Cork MJ, Clay FE. et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997; 136 (01) 147-148
- 35 Qiao J, Jia QN, Jin HZ. Lack of association of the IL-1RN and IL-10 polymorphisms with risk of psoriasis: a meta-analysis. Mol Genet Genomic Med 2019; 7 (01) e00512
- 36 Nair RP, Duffin KC, Helms C. et al; Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41 (02) 199-204
- 37 Kim YK, Pyo CW, Choi HB, Kim SY, Kim TY, Kim TG. Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. J Dermatol Sci 2007; 48 (02) 133-139
- 38 Xu H, Liu J, Niu M. et al. Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis. J Mol Med (Berl) 2021; 99 (07) 1009-1020
- 39 Boca AN, Talamonti M, Galluzzo M. et al. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis. Immunol Lett 2013; 156 (1-2): 127-131
- 40 Nie G, Xie CL, Cao YJ. et al. Meta-analysis of IL-6 -174G/C polymorphism and psoriasis risk. Genet Mol Res 2016;15(02):
- 41 Elneam AIA, Al-Dhubaibi MS, Alrheam A. Angiotensin-Converting Enzyme (ACE) D Allele as a risk factor for Increase Serum Interleukin-6 and Interleukin-8 in psoriasis patients. Open Access Maced J Med Sci 2018; 6 (05) 772-776
- 42 Craven NM, Jackson CW, Kirby B. et al. Cytokine gene polymorphisms in psoriasis. Br J Dermatol 2001; 144 (04) 849-853
- 43 Lee YH, Choi SJ, Ji JD, Song GG. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm Res 2012; 61 (07) 657-663
- 44 Julià A, Tortosa R, Hernanz JM. et al. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet 2012; 21 (20) 4549-4557
- 45 Chang M, Li Y, Yan C. et al. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun 2008; 9 (02) 176-181
- 46 Zhang XJ, Yan KL, Wang ZM. et al. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J Invest Dermatol 2007; 127 (11) 2544-2551
- 47 Sanad EMK, Nazmy NN, Abd-El Hamid El Sayed R, Hamed AM. Interleukin-17A gene single nucleotide polymorphism and its relation to fungal growth in psoriatic patients: a preliminary study. J Cosmet Dermatol 2021
- 48 Villalpando-Vargas FV, Rivera-Valdés JJ, Alvarado-Navarro A. et al. Association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis. Inflamm Res 2021; 70 (10-12): 1201-1210
- 49 Choi BG, Hong JY, Hong JR. et al. The IL17F His161Arg polymorphism, a potential risk locus for psoriasis, increases serum levels of interleukin-17F in an Asian population. Sci Rep 2019; 9 (01) 18921
- 50 Sabry D, Aboraia N, Samir M. A potential association between psoriasin to rs4819554 of IL-17RA gene polymorphism in psoriasis Egyptian patients. Arch Dermatol Res 2020; 312 (04) 273-281
- 51 Batalla A, Coto E, Gómez J. et al. IL17RA gene variants and anti-TNF response among psoriasis patients. Pharmacogenomics J 2018; 18 (01) 76-80
- 52 Kõks S, Kingo K, Rätsep R, Karelson M, Silm H, Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 2004; 5 (08) 662-667
- 53 Chen XY, Jin LW, Chen YW. et al. The association between the IL-20-1723C→G allele on the 1q chromosome and psoriasis triggered or exacerbated by an upper respiratory tract infection in the Chinese Han population. Dermatology 2011; 222 (01) 24-30
- 54 Kingo K, Kõks S, Nikopensius T, Silm H, Vasar E. Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes Immun 2004; 5 (02) 117-121
- 55 Kõks S, Kingo K, Vabrit K. et al. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes Immun 2005; 6 (05) 407-415
- 56 Galimova E, Rätsep R, Traks T, Kingo K, Escott-Price V, Kõks S. Interleukin-10 family cytokines pathway: genetic variants and psoriasis. Br J Dermatol 2017; 176 (06) 1577-1587
- 57 Kingo K, Mössner R, Traks T. et al. Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. J Dermatol Sci 2010; 57 (01) 71-73
- 58 Cargill M, Schrodi SJ, Chang M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80 (02) 273-290
- 59 Capon F, Di Meglio P, Szaub J. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007; 122 (02) 201-206
- 60 Nair RP, Ruether A, Stuart PE. et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008; 128 (07) 1653-1661
- 61 Liu Y, Helms C, Liao W. et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008; 4 (03) e1000041
- 62 Tsunemi Y, Saeki H, Nakamura K. et al. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002; 30 (02) 161-166
- 63 Wu Y, Lu Z, Chen Y, Xue F, Chen X, Zheng J. Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Hum Immunol 2010; 71 (12) 1255-1258
- 64 Nair RP, Stuart PE, Kullavanijaya P. et al. Genetic evidence for involvement of the IL23 pathway in Thai psoriatics. Arch Dermatol Res 2010; 302 (02) 139-143
- 65 Davidson SI, Wu X, Liu Y. et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009; 60 (11) 3263-3268
- 66 Li XL, Wu CF, Wu GS. Genetic variations of cytokines and cytokine receptors in psoriasis patients from China. Int J Genomics 2014; 2014: 870597
- 67 Höhler T, Kruger A, Schneider PM. et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109 (04) 562-565
- 68 Li C, Wang G, Gao Y, Liu L, Gao T. TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. J Invest Dermatol 2007; 127 (08) 1886-1892
- 69 Reich K, Mössner R, König IR, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002; 118 (01) 155-163
- 70 Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 1997; 14 (02) 118-122
- 71 Wang L, Zhou H. A meta-analysis of the relationship between tumor necrosis factor-α polymorphisms and psoriasis. Dermatology 2021; 237 (01) 39-45
- 72 El-Hadidi HH, Hassan AS, El-Hanafy G, Amr KS, Abdelmesih SF, Abdelhamid MF. Transforming growth factor-β1 gene polymorphism in psoriasis vulgaris. Clin Cosmet Investig Dermatol 2018; 11: 415-419
- 73 Baran W, Szepietowski JC, Mazur G, Baran E. TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 2007; 38 (01) 8-11
- 74 Ellinghaus E, Ellinghaus D, Stuart PE. et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010; 42 (11) 991-995
- 75 Hüffmeier U, Uebe S, Ekici AB. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010; 42 (11) 996-999
- 76 Haase O, Mosaad H, Eldarouti MA. et al. TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort. J Eur Acad Dermatol Venereol 2015; 29 (07) 1297-1301
- 77 Gong HB, Gao ST, Pu XM, Kang XJ, Wu XJ. Association of rs610604 in TNFAIP3 and rs17728338 in TNIP1 gene polymorphisms with psoriasis susceptibility: a meta-analysis of case-control studies. BMC Med Genet 2020; 21 (01) 103
- 78 Sabah-Özcan S, Gürel G. The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population. Immunol Lett 2019; 211: 28-32
- 79 Zabłotna M, Sobjanek M, Purzycka-Bohdan D, Szczerkowska-Dobosz A, Nedoszytko B, Nowicki RJ. The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis. Postepy Dermatol Alergol 2017; 34 (01) 85-86
- 80 Shi G, Wang T, Li S. et al. TLR2 and TLR4 polymorphisms in Southern Chinese psoriasis vulgaris patients. J Dermatol Sci 2016; 83 (02) 145-147
- 81 Çakmak G, Dursun A. Relationship between TLR2 and TLR4 gene polymorphisms with psoriasis. Turk J Dermatol 2018; 12: 28-32
- 82 Al Harthi F, Huraib GB, Zouman A, Arfin M, Tariq M, Al-Asmari A. Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis. Dis Markers 2014; 2014: 239645
- 83 Han Y, Liu T, Lu L. Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis. Arch Med Res 2013; 44 (01) 46-53
- 84 Stefanic M, Rucevic I, Barisic-Drusko V. Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk. Int J Dermatol 2013; 52 (06) 705-710
- 85 Ramezani M, Zavattaro E, Sadeghi M. Angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to psoriasis: a systematic review and meta-analysis. BMC Med Genet 2020; 21 (01) 8
- 86 He L, Dang L, Zhou J, Bai J, Li YZ. Association of angiopoietin-1, angiopoietin-2 and caspase-5 polymorphisms with psoriasis vulgaris. Clin Exp Dermatol 2015; 40 (05) 556-563
- 87 Lee YH. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: an updated meta-analysis. Clin Exp Dermatol 2019; 44 (05) 498-505
- 88 Huraib GB, Harthi FA, Arfin M, Khlaiwi AA, Rizvi S, Al-Asmari A. Methylenetetrahydrofolate Reductase C677T gene polymorphism as risk factor for psoriasis in Saudis. Biomark Insights 2019; 14: 1177271919830973
- 89 Wu D, Shi D, Yang L, Zhu X. Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: a meta-analysis. J Dermatol 2016; 43 (02) 162-169
- 90 Zablotna M, Sobjanek M, Nedoszytko B. et al. Association of psoriasis with the VEGF gene polymorphism in the northern Polish population. J Eur Acad Dermatol Venereol 2013; 27 (03) 319-323
- 91 Lee YH, Song GG. Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis. Genet Mol Res 2015; 14 (04) 14396-14405
- 92 Yu P, Liu B, Hao S, Xing R, Li Y. A new risk polymorphism rs10403848 of CARD8 significantly associated with psoriasis vulgaris in Northeastern China. BioMed Res Int 2020; 2020: 2867505
- 93 Shi G, Cheng CM, Wang TT, Li SJ, Fan YM, Zhu KJ. Association between atopic dermatitis-related single nucleotide polymorphisms rs4722404 and psoriasis vulgaris in a southern Chinese cohort. Genet Mol Res 2016;15(02)
- 94 Shi G, Zhang MF, Liao PY. et al. Lack of association between CARD10/CARMA3 tag SNPs and psoriasis vulgaris in the southern Chinese population. Genet Mol Res 2017;16(01):
- 95 González-Lara L, Coto-Segura P, Penedo A. et al. SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort. DNA Cell Biol 2013; 32 (10) 601-604
- 96 Sugiura K, Muto M, Akiyama M. CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort. J Invest Dermatol 2014; 134 (06) 1755-1757
- 97 Feng C, Wang T, Li SJ, Fan YM, Shi G, Zhu KJ. CARD14 gene polymorphism c.C2458T (p.Arg820Trp) is associated with clinical features of psoriasis vulgaris in a Chinese cohort. J Dermatol 2016; 43 (03) 294-297
- 98 Shi G, Li SJ, Wang TT, Cheng CM, Fan YM, Zhu KJ. The common CARD14 gene missense polymorphism rs11652075 (c.C2458T/p.Arg820Trp) is associated with psoriasis: a meta-analysis. Genet Mol Res 2016;15(03):
- 99 Zhu K, Yin X, Tang X, Zhang F, Yang S, Zhang X. Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis. Rheumatol Int 2012; 32 (07) 1893-1900
- 100 Ekman AK, Verma D, Fredrikson M, Bivik C, Enerbäck C. Genetic variations of NLRP1: susceptibility in psoriasis. Br J Dermatol 2014; 171 (06) 1517-1520
- 101 Carlström M, Ekman AK, Petersson S, Söderkvist P, Enerbäck C. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp Dermatol 2012; 21 (12) 932-937
- 102 Yu P, Hao S, Zheng H, Zhao X, Li Y. Association of NLRP1 and NLRP3 polymorphisms with psoriasis vulgaris risk in the Chinese Han population. BioMed Res Int 2018; 2018: 4714836
- 103 Kim SY, Hur MS, Choi BG. et al. A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population. Clin Exp Immunol 2017; 187 (02) 251-258
- 104 Sayed KS, El-Komy MHM, Shehata H. et al. JAK1 rs310241 and JAK3 rs3008 genotypes may increase susceptibility to psoriasis: a case control study. Skin Pharmacol Physiol 2020; 33 (04) 207-212
- 105 Zhou J, Li Y, Sun D. Associations between STAT gene polymorphisms and psoriasis in Northeastern China. Dermatology 2017; 233 (01) 30-36
- 106 Wang W, Zhu Z, Zhu C. et al. A genetic variant rs1020760at NFKB1 is associated with clinical features of psoriasis vulgaris in a Han Chinese population. Ann Hum Genet 2016; 80 (04) 197-202
- 107 Mei Q, Liu C, Zhang X. et al. Associations between PTPN2 gene polymorphisms and psoriasis in Northeastern China. Gene 2019; 681: 73-79
- 108 Bin Huraib G, Al Harthi F, Arfin M, Rizvi S, Al-Asmari A. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) R620W functional polymorphism in psoriasis. Clin Med Insights Arthritis Musculoskelet Disord 2018; 11: 1179544117751434
- 109 Dizen-Namdar N, Akcilar R, Bayat Z. Association between Vaspin rs2236242 gene polymorphism and psoriasis vulgaris. Skin Pharmacol Physiol 2020; 33 (06) 317-322
- 110 Xia T, Diao J, Huang H. et al. Evaluation of the association between CD143 gene polymorphism and psoriasis. Cell Biochem Biophys 2014; 70 (03) 1617-1623
- 111 Hua S, Fan B, Mao W. et al. Association between PDCD1 gene polymorphisms and psoriasis susceptibility in the Chinese population. Int J Dermatol 2021; 60 (11) 1411-1417
- 112 Han J, Xiao J, Wu Q, Hao L. Association of ADAM33 gene polymorphisms with psoriasis in a northeastern Chinese population. Mol Biol Rep 2014; 41 (06) 4001-4005
- 113 Rajesh D, Nagraj S, Kumar KSP, Kutty AVM, Balakrishna S. Evaluation of HCP5 and Chemokine C Receptor type 5 Gene Polymorphisms in Indian psoriatic patients. Indian J Dermatol 2019; 64 (03) 182-186